International Off-Patent Industry's Wishlist For WHO Pandemic Accord
As the WHO seeks input on a global accord to strengthen pandemic preparedness, the IGBA has provided suggestions from the off-patent industry ahead of a key step in the drafting process later this month.
You may also be interested in...
Teva Wraps Up Nationwide US Opioids Settlement
Teva has formally concluded its nationwide settlement agreement over opioids litigation in the US with all 50 states – including holdout Nevada – removing a significant legal overhang for the company.
Murphy Named As OGD Director At US FDA
The FDA has announced that agency veteran Iilun Murphy will take over leadership of its Office of Generic Drugs. At the same time, CDER principal deputy center director and chair of the GDUFA steering committee Jacqueline Corrigan-Curay will assume oversight of OGD and the FDA’s generics program.
Samsung Biologics Strikes $400m+ Biosimilars Supply Deal With Pfizer
Samsung Biologics has struck a deal worth over $400m to manufacture multiple biosimilars for Pfizer.